RESEARCH-USE BIOSIMILAR ANTIBODY

Trevogrumab

Monoclonal antibody · IgG4

MSTNIgG4RUO

Trevogrumab (REGN-1033) is a monoclonal antibody targeting GDF8 (growth differentiation factor 8, also known as myostatin). Trevogrumab is used in research on muscle wasting conditions, including disuse atrophy, chronic diseases, and changes in food and nutrient intake.

TARGETMSTN
YMonoclonal antibody
CATALOGSC-BS-083
CATALOG NUMBERSC-BS-083
MOLECULAR WEIGHTApprox. 144.04 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Trevogrumab (REGN-1033) is a monoclonal antibody targeting GDF8 (growth differentiation factor 8, also known as myostatin). Trevogrumab is used in research on muscle wasting conditions, including disuse atrophy, chronic diseases, and changes in food and nutrient intake.

Trevogrumab is a recombinant research-use antibody directed against MSTN.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Trevogrumab | StellaCyte